ILD & Early Rheumatoid Arthritis

Trial Objective

ILD and Early Rheumatoid ArthritisThe purpose of this study is to learn how interstitial lung disease (ILD) develops and progresses over time in people with early rheumatoid arthritis (RA). There is evidence that RA starts in the lungs in a subset of patients and through this study researchers will be looking at the relationship between your RA and your lungs.

Enrollment

This trial is active and currently recruiting.

Who Can Participate

Adults diagnosed with rheumatoid arthritis within the last two years may be eligible to participate.

Age: 18-90    Gender: Any Gender


Estimated Time Commitment

5 in-person visits over 18 months



Compensation

Not Provided

Trial Contact

For more information, contact:

Faduma Ahmed, Trial Coordinator

Faduma Ahmed
303.398.1285

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

Boehringer Ingelheim

Co-Investigators


Request More Information

*
*
*
*